Number of subjects: 58 post-menopausal women with a mean age of 61 years old for both groups.Control: 29 controls without breast cancer. Case: 29 subjects with breast cancer on aromatase inhibitors. This evidence concerns the gene CYP19A1 and breast carcinoma.